REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/07/2026
Back to search
Official data from USPTO
TRINTELLIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
02/08/2026
Trademark type
Combined
Nice classes
5
Filing date
07/19/2016
Registration date
02/07/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/31/2023
Last transaction
02/08/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
06/01/2016
First use in commerce
06/01/2016
Drawing code
3
Owner type
99
Owner location
Valby, DK
Examiner
BHANOT, KAPIL KUMAR
Law office
L80
Current location
TMEG LAW OFFICE 108
Mark description
The mark consists of the wording "TRINTELLIX" in stylized blue-green font with the dot over the first letter "I" represented by concentric orange circles with the upper portion of each circle faded out. The color white appearing in the drawing represents background or transparent regions and is not claimed as a feature of the mark.
Holders and representatives
Holders
H. Lundbeck A/S
H. Lundbeck A/S
Representatives
Maren C. Perry King & Spalding LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases ingenerated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of depressioncognitive disordersmood disorders; pharmaceuticals for treatment of cognitive disorders and diseases
Publications
History of USPTO decisions and trademark events.
20 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/22/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/22/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
03/22/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/22/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/22/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/31/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/31/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/31/2023
E815
TEAS SECTION 8 & 15 RECEIVED
02/02/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/07/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/07/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/22/2016
PUBO
PUBLISHED FOR OPPOSITION
11/22/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/02/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/12/2016
DOCK
ASSIGNED TO EXAMINER
10/12/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/26/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/23/2016
NWAP
NEW APPLICATION ENTERED
07/22/2016
Continuous trademark protection
Get notified about every new filing that threatens TRINTELLIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.